IBEX Announces Second Quarter of Fiscal Year 2024 Financial Results

Rhea-AI Summary

IBEX Limited announced financial results for its second fiscal quarter ended December 31, 2023, highlighting eight new client wins and strategic investments in AI capabilities. However, the company reported a 4.8% decline in revenue and a decrease in net income. IBEX also provided updated guidance for fiscal year 2024, expecting revenues between $505 and $510 million and an adjusted EBITDA margin of 12-13%.

Positive

• Eight new client relationships won across various sectors
• Strategic investments in AI capabilities and sales organization
• Expected improvement in adjusted EBITDA margins in the second half of fiscal year 2024

Negative

• 4.8% decline in revenue compared to the prior year quarter
• Decrease in net income and earnings per share
• Adverse impact to revenue and EBITDA associated with the deferral of revenue for new logo and client ramps
• Decrease in adjusted EBITDA and adjusted EBITDA margin

Insights

Financial Analyst

IBEX Limited's reported decline in revenue and net income for the second fiscal quarter is indicative of a challenging period for the company. The 4.8% year-over-year decrease in revenue and the drop in net income from $9.3 million to $6.1 million reflect pressures on the company's financial performance. However, it's important to highlight the strategic investments in sales and artificial intelligence capabilities that IBEX is making to position itself for future growth. These investments, while contributing to short-term financial strain, could potentially lead to an improved competitive edge and long-term profitability.

The company's focus on growing its client base in HealthTech, FinTech, Retail & E-Commerce and emerging technology sectors aligns with industry trends towards digital transformation and increased reliance on tech-driven solutions. The eight new client wins in the quarter, bringing the total to twelve for the fiscal year, suggest that IBEX's strategy may be resonating with potential clients. However, the softness in client volumes leading to lower revenues raises questions about the company's current market position and the scalability of its business model.

Another point of concern for stakeholders could be the reduced net cash provided by operating activities and the decline in free cash flow, which turned negative to $(4.5) million. This could signal liquidity challenges and may affect the company's ability to sustain its share repurchase program without impacting operational needs. The updated full-year guidance, with an expected adjusted EBITDA margin of 12-13%, will be a key metric for investors to watch, as it will indicate the company's operational efficiency and ability to manage expenses in relation to revenue.

Market Research Analyst

From a market perspective, IBEX Limited's performance in the second fiscal quarter highlights several industry-specific trends. The shift in delivery from onshore to offshore indicates a continued trend in the BPO sector towards cost optimization. Companies are increasingly seeking out offshore solutions to leverage cost advantages, which can be a double-edged sword as it may also lead to pricing pressures and competition in these regions.

The mention of adverse impacts due to the deferral of revenue for new logo and client ramps suggests that the company is in a transitional phase, with future revenues being contingent on the successful scaling of these new relationships. This is a common occurrence in the BPO industry, where the time to ramp up new clients can lead to short-term revenue volatility. Investors and analysts will be closely monitoring the ramp-up period and the subsequent revenue contribution from these new clients.

The company's emphasis on AI capabilities is particularly noteworthy as it reflects the growing demand for innovation in the BPO industry. Clients are seeking partners who can provide not just traditional contact center services, but also advanced AI-driven solutions to improve efficiency and customer experience. IBEX's ability to secure new clients in this space could be a significant growth driver, provided that these solutions are effectively integrated and deliver the expected value to clients.

Economist

The economic implications of IBEX Limited's financial results extend beyond the company itself, reflecting broader economic trends. The BPO industry is sensitive to economic cycles and the softness in client volumes may be indicative of wider economic headwinds or sector-specific challenges. The company's strategic decision to invest in AI and expand its sales organization, despite the current financial pressures, suggests a long-term vision that prioritizes adaptation to technological advancements and market demands over immediate financial gains.

IBEX's updated guidance, with lower anticipated revenues and adjusted EBITDA margins, signals caution in the face of uncertain market conditions. The cautious outlook could be reflective of the company's conservative approach in an unpredictable economic environment. The ability of IBEX to navigate these conditions and the success of its strategic investments will be critical in determining its market position and financial health in the coming years.

Overall, the company's financial performance and future guidance offer insights into the BPO sector's responsiveness to global economic shifts and the increasing importance of technological innovation as a competitive differentiator.

WASHINGTON, Feb. 08, 2024 (GLOBE NEWSWIRE) -- IBEX Limited (“ibex”), a leading provider in global business process outsourcing and end-to-end customer engagement technology solutions, today announced financial results for its second fiscal quarter ended December 31, 2023.

“We delivered against a number of our key objectives in the second quarter, highlighted by the eight new client wins in the quarter, totaling twelve in the first half of the fiscal year versus seven in the prior year period,” commented Bob Dechant, CEO of ibex. “That being said, softness in volumes with several of our clients have put recent pressure on our top and bottom line and our second quarter reflected that. To ensure that we resume our historical growth leadership position, we have been making strategic investments in our building blocks for our next stage of growth over the last 12 months including expansion of our sales organization and enhancing our AI capabilities. We are now seeing momentum build in terms of size, speed and quality of our pipeline and wins. Clients are now looking for BPO partners who can not only deliver great contact center solutions, but also rapidly deploy disruptive AI-based solutions for them. Our recent wins and strength of our pipeline highlight our ability to win on both fronts and positions us for growth as we move forward,” added Dechant.

Second Quarter 2024 Key Highlights

• Eight new client relationships won across HealthTech, FinTech, Retail & E-Commerce and new emerging Technology companies, totaling twelve for the year to date compared to seven in the prior year period.
  

GAAP Financials:

• Second quarter revenue of $132.6 million declined 4.8% from the prior year quarter.
• Net income was $6.1 million compared to $9.3 million in the prior year quarter. Net income margin was 4.6% compared to 6.7% in the prior year quarter.
• Diluted earnings per share were $0.33 compared to $0.49 in the prior year quarter.
  

Non-GAAP Financial Measures:

• Adjusted net income was $8.0 million compared to $12.2 million in the prior year quarter.
• Adjusted earnings per share were $0.44 compared to $0.65 in the prior year quarter.
• Adjusted EBITDA was $14.3 million compared to $19.4 million in the prior year quarter. Adjusted EBITDA margin was 10.8% compared to 13.9% in the prior year quarter.
  

Other Metrics:

• $2.3 million adverse impact realized year over year to revenue and EBITDA associated with the deferral of revenue for new logo and client ramps.
• Repurchased 488,803 shares at a total cost of $8.4 million in the second quarter, and a total of 740,346 shares through January 31, 2024 at a total cost of $12.5 million fiscal year to date.

Second Quarter Financial Performance
Revenue

• Revenue was $132.6 million, compared to $139.3 million in the prior year quarter, a decrease of 4.8%. Revenues were impacted by lower volumes in certain verticals and the year over year shift of delivery from onshore to offshore regions.
• $2.3 million adverse impact to revenue compared to the prior year quarter associated with the deferral of training revenue for new logo and client ramps.
• Growth in our strategic HealthTech and Retail & E-Commerce verticals partly offset the above-mentioned revenue declines in our FinTech and Telecommunications verticals.
  

Net Income and Earnings Per Share

• Net income was $6.1 million compared to $9.3 million in the prior year quarter. Diluted earnings per share were $0.33 compared to $0.49 in the prior year quarter. The decreases were primarily driven by the adverse impact of the $2.3 million deferred training revenue, as well as strategic investments made for the business in technology and sales & marketing, resulting in lower income from operations.
• Net income margin was 4.6% compared to 6.7% in the prior year quarter.
• Non-GAAP adjusted net income was $8.0 million compared to $12.2 million in the prior year quarter. Non-GAAP adjusted diluted earnings per share were $0.44 compared to $0.65 in the prior year quarter (see Exhibit 1 for reconciliation). The decrease per share was primarily attributable to the impact of deferred training revenue and the noted strategic investments in growth.
  

Adjusted EBITDA

• Adjusted EBITDA was $14.3 million compared to $19.4 million in the prior year quarter (see Exhibit 2 for reconciliation), driven by the aforementioned factors related to deferred training revenue and strategic investments.
• Adjusted EBITDA margin was 10.8% compared to 13.9% in the prior year quarter, the decline for which is attributable to the two key factors noted above (see Exhibit 2 for reconciliation).

Cash Flow and Balance Sheet

• Net cash provided by operating activities decreased to $(1.6) million compared to $5.3 million in the prior year quarter.
• Capital expenditures were $2.9 million compared to $7.9 million in the prior year quarter.
• Free cash flow decreased to $(4.5) million, compared to $(2.7) million in the prior year quarter (see Exhibit 3 for reconciliation).
• Cash and cash equivalents was $49.0 million as of December 31, 2023, compared to cash and cash equivalents of $57.4 million as of June 30, 2023. The decline in cash is attributable to the share repurchase program.
• Net cash position was $48.0 million as of December 31, 2023, compared to $56.4 million as of June 30, 2023 (see Exhibit 4 for reconciliation).
  

“We believe in our overall business fundamentals and the differentiated value proposition we bring to our clients. However, softness in several of our client volumes has resulted in lower revenues,” said Taylor Greenwald, CFO of ibex. “We expect this volume trajectory to continue for the near term, and, therefore, expect third quarter revenues to trend similarly as the first two quarters on a year over year basis. As our new client ramps reach scale in the fourth quarter, we anticipate an inflection towards growth. We remain confident our strategy of driving growth in our higher margin offshore regions, accelerated by new client wins, and realizing cost savings through optimizing our site footprint will drive improvement in adjusted EBITDA margins for the second half of our fiscal year and in the years ahead.”

“As a result we are updating our Full Year guidance as follows: On a full year basis we expect revenues to be between $505 and $510 million and adjusted EBITDA margin in the range of 12-13%.”

Fiscal Year 2024 Guidance

• Fiscal year 2024 revenue between $505 to $510 million.
• Adjusted EBITDA margin of approximately 12-13%.
• Capital expenditures of $15 to $20 million.

Conference Call and Webcast Information
IBEX Limited will host a conference call and live webcast to discuss its second quarter of fiscal year 2024 financial results at 4:30 p.m. Eastern Time today, February 8, 2024. We will also post to this section of our website the earning slides, which will accompany our conference call and live webcast, and encourage you to review the information that we make available on our website.

Live and archived webcasts can be accessed at: https://investors.ibex.co/.

Financial Information
This announcement does not contain sufficient information to constitute an interim financial report as defined in Financial Accounting Standards ASC 270, “Interim Reporting.” The financial information in this press release has not been audited.

Non-GAAP Financial Measures

We present non-GAAP financial measures because we believe that they and other similar measures are widely used by certain investors, securities analysts and other interested parties as supplemental measures of performance and liquidity. We also use these measures internally to establish forecasts, budgets and operational goals to manage and monitor our business, as well as evaluate our underlying historical performance, as we believe that these non-GAAP financial measures provide a more helpful depiction of our performance of the business by encompassing only relevant and manageable events, enabling us to evaluate and plan more effectively for the future. The non-GAAP financial measures may not be comparable to other similarly titled measures of other companies, have limitations as analytical tools, and should not be considered in isolation or as a substitute for analysis of our operating results as reported in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”). Non-GAAP financial measures and ratios are not measurements of our performance, financial condition or liquidity under U.S. GAAP and should not be considered as alternatives to operating profit or net income / (loss) or as alternatives to cash flow from operating, investing or financing activities for the period, or any other performance measures, derived in accordance with U.S. GAAP.

ibex is not providing a quantitative reconciliation of forward-looking non-GAAP adjusted EBITDA margin to the most directly comparable GAAP measure because it is unable to predict with reasonable certainty the ultimate outcome of certain significant items without unreasonable effort. These items include, but are not limited to, non-recurring expenses, foreign currency gains or losses, and share-based compensation expense. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance period.

About ibex
ibex helps the world’s preeminent brands more effectively engage their customers with services ranging from customer support, technical support, inbound/outbound sales, business intelligence and analytics, digital demand generation, and CX surveys and feedback analytics.

Forward Looking Statements
In addition to historical information, this release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terminology such as “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “expect,” “predict,” “potential,” or the negative of these terms or other similar expressions. These statements include, but are not limited to, statements regarding our future financial and operating performance, including our outlook and guidance, and our strategies, priorities and business plans. Our expectations and beliefs regarding these matters may not materialize, and actual results in future periods are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Factors that could impact our actual results include: general economic uncertainty in global markets and unfavorable economic conditions, including inflation, rising interest rates, recession, foreign exchange fluctuations and supply-chain issues; geopolitical conditions, including developing or ongoing conflicts; our ability to attract new business and retain key clients; our profitability based on our utilization, pricing and managing costs; the potential for our clients or potential clients to consolidate; our clients deciding to enter into or further expand their insourcing activities and current trends toward outsourcing services may reverse; our ability to manage our international operations, particularly in the Philippines, Jamaica, Pakistan and Nicaragua; our ability to anticipate, develop and implement information technology solutions that keep pace with evolving industry standards and changing client demands, including the effective adoption of Artificial Intelligence into our offerings; our ability to recruit, engage, motivate, manage and retain our global workforce; our ability to comply with applicable laws and regulations, including those regarding privacy, data protection and information security, employment and anti-corruption; the effect of cyberattacks or cybersecurity vulnerabilities on our information technology systems; our ability to realize the anticipated strategic and financial benefits of our relationship with Amazon; and other factors discussed in the “Risk Factors” described in our periodic reports filed with the U.S. Securities and Exchange Commission (“SEC”), including our annual reports on Form 10-K, quarterly reports on Form 10-Q, and past filings on Form 20-F, and any other risk factors we include in subsequent filings with the SEC. Because of these uncertainties, you should not make any investment decisions based on our estimates and forward-looking statements. Except as required by law, we undertake no obligation to publicly update any forward-looking statements for any reason after the date of this press release whether as a result of new information, future events or otherwise.

IR Contact:  Michael Darwal, EVP, Investor Relations, ibex, michael.darwal@ibex.co
Media Contact:  Daniel Burris, Senior Director PR and Communication, ibex, daniel.burris@ibex.co

IBEX LIMITED AND SUBSIDIARIES Consolidated Balance Sheets (Unaudited) (in thousands)
	December 31, 2023				June 30, 2023
Assets
Current assets
Cash and cash equivalents	$	49,016			$	57,429
Accounts receivable, net		104,747				86,364
Prepaid expenses		5,278				6,616
Due from related parties		129				43
Tax advances and receivables		8,367				5,965
Other current assets		1,956				2,190
Total current assets		169,493				158,607
Non-current assets
Property and equipment, net		35,950				41,151
Operating lease assets		69,190				70,919
Goodwill		11,832				11,832
Deferred tax asset, net		4,289				4,585
Other non-current assets		7,420				6,230
Total non-current assets		128,681				134,717
Total assets	$	298,174			$	293,324
Liabilities and stockholders' equity
Current liabilities
Accounts payable and accrued liabilities	$	17,934			$	18,705
Accrued payroll and employee-related liabilities		32,387				29,360
Current deferred revenue		6,463				6,413
Current operating lease liabilities		13,608				13,036
Current maturities of long-term debt		441				413
Due to related parties		54				2,314
Income taxes payable		3,346				3,020
Total current liabilities		74,233				73,261
Non-current liabilities
Non-current deferred revenue		1,634				1,383
Non-current operating lease liabilities		62,406				64,854
Long-term debt		560				600
Other non-current liabilities		3,228				3,262
Total non-current liabilities		67,828				70,099
Total liabilities		142,061				143,360
Stockholders' equity
Common stock		2				2
Additional paid-in capital		207,638				204,734
Treasury stock		(14,116	)			(3,682	)
Accumulated other comprehensive loss		(6,133	)			(6,312	)
Accumulated deficit		(31,278	)			(44,778	)
Total stockholders' equity		156,113				149,964
Total liabilities and stockholders' equity	$	298,174			$	293,324

IBEX LIMITED AND SUBSIDIARIES Consolidated Statements of Comprehensive Income (Unaudited) (in thousands, except per share data)
	Three Months Ended December 31,								Six Months Ended December 31,
		2023				2022				2023				2022
Revenue	$	132,634			$	139,325			$	257,243			$	267,130
Cost of services (exclusive of depreciation and amortization presented separately below)		95,884				99,790				184,080				195,943
Selling, general and administrative		24,857				23,502				47,897				42,807
Depreciation and amortization		4,946				4,582				9,988				9,259
Total operating expenses		125,687				127,874				241,965				248,009
Income from operations		6,947				11,451				15,278				19,121
Interest income		512				138				1,098				186
Interest expense		(111	)			(300	)			(215	)			(448	)
Income before income taxes		7,348				11,289				16,161				18,859
Provision for income tax expense		(1,273	)			(2,019	)			(2,661	)			(3,066	)
Net income	$	6,075			$	9,270			$	13,500			$	15,793
Other comprehensive income / (loss)
Foreign currency translation adjustments	$	679			$	554			$	(22	)		$	(1,123	)
Unrealized gain on cash flow hedging instruments, net of tax		395				814				201				553
Total other comprehensive gain / (loss)		1,074				1,368				179				(570	)
Total comprehensive income	$	7,149			$	10,638			$	13,679			$	15,223
Net income per share
Basic	$	0.34			$	0.51			$	0.75			$	0.87
Diluted	$	0.33			$	0.49			$	0.72			$	0.84
Weighted average common shares outstanding
Basic		17,885				18,149				18,084				18,154
Diluted		18,440				18,860				18,667				18,759

IBEX LIMITED AND SUBSIDIARIES Consolidated Statements of Cash Flows (Unaudited) (in thousands)
	Three Months Ended December 31,								Six Months Ended December 31,
		2023				2022				2023				2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income	$	6,075			$	9,270			$	13,500			$	15,793
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization		4,946				4,582				9,988				9,259
Noncash lease expense		3,297				3,719				6,522				7,273
Warrant contra revenue		307				310				594				596
Deferred income tax		52				1,214				296				1,506
Share-based compensation expense		1,427				1,533				2,275				2,655
Allowance of expected credit losses		(5	)			115				6				117
Change in assets and liabilities:
Increase in accounts receivable		(14,544	)			(11,381	)			(18,336	)			(18,272	)
(Increase) / decrease in prepaid expenses and other current assets		(936	)			3,366				(2,192	)			3,223
Increase / (decrease) in accounts payable and accrued liabilities		338				(2,151	)			544				(1,282	)
Increase / (decrease) in deferred revenue		673				(1,640	)			301				(2,905	)
Decrease in operating lease liabilities		(3,267	)			(3,644	)			(6,451	)			(7,108	)
Net cash / (outflow) inflow from operating activities		(1,637	)			5,293				7,047				10,855
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(2,892	)			(7,948	)			(4,944	)			(11,506	)
Net cash outflow from investing activities		(2,892	)			(7,948	)			(4,944	)			(11,506	)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from line of credit		59				29,959				96				39,314
Repayments of line of credit		(59	)			(32,300	)			(148	)			(46,300	)
Repayment of debt		—				(838	)			—				(3,524	)
Proceeds from the exercise of options		6				1,188				11				1,209
Principal payments on finance leases		(116	)			(186	)			(204	)			(266	)
Purchase of treasury shares		(8,442	)			—				(10,274	)			(276	)
Net cash outflow from financing activities		(8,552	)			(2,177	)			(10,519	)			(9,843	)
Effects of exchange rate difference on cash and cash equivalents		68				63				3				(255	)
Net decrease in cash and cash equivalents		(13,013	)			(4,769	)			(8,413	)			(10,749	)
Cash and cash equivalents, beginning		62,029				42,851				57,429				48,831
Cash and cash equivalents, ending	$	49,016			$	38,082			$	49,016			$	38,082

IBEX LIMITED AND SUBSIDIARIES
Reconciliation of GAAP Financial Measures to Non-GAAP Financial Measures

EXHIBIT 1: Adjusted net income and adjusted earnings per share
We define adjusted net income as net income before the effect of the following items: non-recurring expenses (including legal and settlement costs), warrant contra revenue, foreign currency gains or losses, and share-based compensation expense, net of the tax impact of such adjustments. We define adjusted earnings per share as adjusted net income divided by weighted average diluted shares outstanding. The following table provides a reconciliation of net income to adjusted net income and diluted earnings per share to adjusted earnings per share for the periods presented:

($000s, except per share amounts)	Three Months Ended December 31,								Six Months Ended December 31,
		2023				2022				2023				2022
Net income	$	6,075			$	9,270			$	13,500			$	15,793
Net income margin		4.6	%			6.7	%			5.2	%			5.9	%
Non-recurring expenses		—				792				—				792
Warrant contra revenue		307				310				594				596
Foreign currency losses / (gains)		697				752				(100	)			(97	)
Share-based compensation expense		1,427				1,533				2,275				2,655
Total adjustments	$	2,431			$	3,387			$	2,769			$	3,946
Tax impact of adjustments1		(482	)			(425	)			(671	)			(710	)
Adjusted net income	$	8,024			$	12,232			$	15,598			$	19,029
Adjusted net income margin		6.0	%			8.8	%			6.1	%			7.1	%
Diluted earnings per share	$	0.33			$	0.49			$	0.72			$	0.84
Per share impact of adjustments to net income		0.11				0.16				0.12				0.17
Adjusted earnings per share	$	0.44			$	0.65			$	0.84			$	1.01
Weighted average diluted shares outstanding		18,440				18,860				18,667				18,759

_{________________________
¹The tax impact of each adjustment is calculated using the effective tax rate in the relevant jurisdictions.}

EXHIBIT 2:  EBITDA, adjusted EBITDA, and adjusted EBITDA margin
EBITDA is a non-GAAP profitability measure that represents net income before the effect of the following items: interest expense, income tax expense, and depreciation and amortization. Adjusted EBITDA is a non-GAAP profitability measure that represents EBITDA before the effect of the following items: non-recurring expenses (including legal and settlement costs), interest income, warrant contra revenue, foreign currency gains or losses, and share-based compensation expense. Adjusted EBITDA margin is a non-GAAP profitability measure that represents adjusted EBITDA divided by revenue. The following table provides a reconciliation of net income and net income margin to adjusted EBITDA and adjusted EBITDA margin for the periods presented:

	Three Months Ended December 31,								Six Months Ended December 31,
($000s)		2023				2022				2023				2022
Net income	$	6,075			$	9,270			$	13,500			$	15,793
Net income margin		4.6	%			6.7	%			5.2	%			5.9	%
Interest expense		111				300				215				448
Income tax expense		1,273				2,019				2,661				3,066
Depreciation and amortization		4,946				4,582				9,988				9,259
EBITDA	$	12,405			$	16,171			$	26,364			$	28,566
Non-recurring expenses		—				792				—				792
Interest income		(512	)			(138	)			(1,098	)			(186	)
Warrant contra revenue		307				310				594				596
Foreign currency losses / (gains)		697				752				(100	)			(97	)
Share-based compensation expense		1,427				1,533				2,275				2,655
Adjusted EBITDA	$	14,324			$	19,420			$	28,035			$	32,326
Adjusted EBITDA margin		10.8	%			13.9	%			10.9	%			12.1	%

EXHIBIT 3: Free cash flow
We define free cash flow as net cash provided by operating activities less capital expenditures.

	Three Months Ended December 31,								Six Months Ended December 31,
($000s)		2023				2022				2023				2022
Net cash / (used in) provided by operating activities	$	(1,637	)		$	5,293			$	7,047			$	10,855
Less: capital expenditures		2,892				7,948				4,944				11,506
Free cash flow	$	(4,529	)		$	(2,655	)		$	2,103			$	(651	)

EXHIBIT 4: Net cash
We define net cash as total cash and cash equivalents less debt.

	December 31,				June 30,
($000s)		2023				2023
Cash and cash equivalents	$	49,016			$	57,429
Debt
Current	$	441			$	413
Non-current		560				600
Total debt	$	1,001			$	1,013
Net cash	$	48,015			$	56,416

FAQ

What were IBEX Limited's second quarter revenue and net income?

IBEX Limited reported second quarter revenue of $132.6 million, a 4.8% decline from the prior year quarter, and net income of $6.1 million.

What were the key highlights of IBEX Limited's second quarter financial performance?

The key highlights included eight new client relationships won across various sectors and strategic investments in AI capabilities and sales organization.

What is IBEX Limited's fiscal year 2024 revenue guidance?

IBEX Limited expects revenues to be between $505 and $510 million for fiscal year 2024.

What is IBEX Limited's expected adjusted EBITDA margin for fiscal year 2024?

IBEX Limited expects an adjusted EBITDA margin of 12-13% for fiscal year 2024.

What were the adverse impacts on revenue and EBITDA for IBEX Limited?

IBEX Limited experienced a $2.3 million adverse impact to revenue and EBITDA associated with the deferral of revenue for new logo and client ramps.

What were the cash flow and balance sheet details for IBEX Limited?

Net cash provided by operating activities decreased to $(1.6) million compared to $5.3 million in the prior year quarter, and cash and cash equivalents was $49.0 million as of December 31, 2023.

What were the key factors contributing to the decline in adjusted EBITDA for IBEX Limited?

The decline in adjusted EBITDA was driven by factors related to deferred training revenue and strategic investments.